Technical420 Site Search

Earlier this week, Aphria Inc. (APHA.TO) (APHA) reported a major development as it relates to the European Union’s (EU) cannabis market and believes that our readers need to be aware of the significance of the announcement as it relates to the previously announced mega-merger with Tilray Inc. (TLRY). As standalone…

So far this year, Tilray Inc. (TLRY) has been one of the most highly talked about Canadian cannabis companies and we attribute the spike in interest to the pending mega-merger with Aphria Inc. (APHA.TO) (APHA). Following the merger announcement, Tilray surged to the upside as the market started to recognize…

When compared to other mergers and acquisitions (M&A) in the cannabis industry, the Aphria Inc. (APHA.TO) (APHA) and Tilray, Inc. (TLRY) merger is one of the most significant transactions to be reported by the cannabis sector in recent years. We considered the combined company to be a leading play on…

Although Tilray Inc. (TLRY) reported strong fourth quarter financials and recorded a more than 20% increase in revenue when compared to the same period last year, broker-dealers have not responded as favorably as we anticipated. Following the earnings report, Tilray was downgraded by two broker-dealers and we found this to…

Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today reported financial results for the full fiscal year and fourth quarter ended December 31, 2020. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. Brendan…

2021 has already proven to be a very active year for Tilray Inc. (TLRY) and we are not even halfway through February. So far this year, Tilray has rallied more than 100% and has been a top performing cannabis stock. Although the market became conditioned to Tilray’s volatile price swings…

Tilray Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has established an agreement with Grow Pharma to import and distribute Tilray’s medical cannabis products into the United Kingdom (UK). This agreement allows Tilray to provide authorized UK patients in need with a…

2021 is already proving to be a great year for the cannabis industry and Canada has been one of the greatest beneficiaries of this. So far this year, the merger between Aphria (APHA.TO) (APHA) and Tilray (TLRY) has been one of the most highly discussed topics and investors have been…

From a merger and acquisition (M&A) standpoint, the cannabis sector recently seen a spike in activity, and this is a trend that we expect to become more significant over the next few years. Last week, GW Pharmaceuticals plc (GWPH) reported to have entered into a definitive agreement with Jazz Pharmaceuticals…

Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced it has agreed with Worldpharma Biotech, through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda., to export Good Manufacturing Processes (GMP) certified medical cannabis from Portugal to Spain. The shipment marks the first medical cannabis…